array:24 [
  "pii" => "S0300289619305745"
  "issn" => "03002896"
  "doi" => "10.1016/j.arbres.2019.11.007"
  "estado" => "S300"
  "fechaPublicacion" => "2020-10-01"
  "aid" => "2324"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "edi"
  "cita" => "Arch Bronconeumol. 2020;56:617-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 60
    "formatos" => array:2 [
      "HTML" => 31
      "PDF" => 29
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S157921292030207X"
      "issn" => "15792129"
      "doi" => "10.1016/j.arbr.2019.11.018"
      "estado" => "S300"
      "fechaPublicacion" => "2020-10-01"
      "aid" => "2324"
      "copyright" => "SEPAR"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "edi"
      "cita" => "Arch Bronconeumol. 2020;56:617-8"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Duration of anticoagulant therapy after pulmonary embolism can be a tough decision"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "617"
            "paginaFinal" => "618"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Duraci&#243;n de la anticoagulaci&#243;n tras una tromboembolia de pulm&#243;n&#58; una decisi&#243;n no siempre sencilla"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Andr&#233;s Quezada, David Jim&#233;nez"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Andr&#233;s"
                "apellidos" => "Quezada"
              ]
              1 => array:2 [
                "nombre" => "David"
                "apellidos" => "Jim&#233;nez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0300289619305745"
          "doi" => "10.1016/j.arbres.2019.11.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305745?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921292030207X?idApp=UINPBA00003Z"
      "url" => "/15792129/0000005600000010/v1_202010020808/S157921292030207X/v1_202010020808/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0300289619305836"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2019.11.013"
    "estado" => "S300"
    "fechaPublicacion" => "2020-10-01"
    "aid" => "2333"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "edi"
    "cita" => "Arch Bronconeumol. 2020;56:619-20"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14
      "formatos" => array:2 [
        "HTML" => 8
        "PDF" => 6
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "La fisioterapia respiratoria en el s&#237;ndrome de <span class="elsevierStyleItalic">Lady Windermere</span>&#58; &#191;el eslab&#243;n perdido&#63;"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "619"
          "paginaFinal" => "620"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Respiratory Physiotherapy in Lady Windermere Syndrome&#58; The Missing Link&#63;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Bala&#241;&#225; Corber&#243;, Marisol Dom&#237;nguez-&#193;lvarez, Esther Barreiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Bala&#241;&#225; Corber&#243;"
            ]
            1 => array:2 [
              "nombre" => "Marisol"
              "apellidos" => "Dom&#237;nguez-&#193;lvarez"
            ]
            2 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Barreiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212920302081"
        "doi" => "10.1016/j.arbr.2019.11.019"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212920302081?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305836?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305836/v2_202010270642/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0300289619305733"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2019.11.006"
    "estado" => "S300"
    "fechaPublicacion" => "2020-10-01"
    "aid" => "2323"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "edi"
    "cita" => "Arch Bronconeumol. 2020;56:615-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 38
      "formatos" => array:2 [
        "HTML" => 23
        "PDF" => 15
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "&#191;Estad&#237;sticamente significativo o cl&#237;nicamente Important&#63;"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "615"
          "paginaFinal" => "616"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Statistically Significant or Clinically Relevant&#63;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 903
              "Ancho" => 2085
              "Tamanyo" => 116441
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Interpretaci&#243;n de la relevancia cl&#237;nica de ejemplos de intervalos de confianza al 95&#37;&#44; en el que se ha establecido el umbral para la diferencia m&#237;nima cl&#237;nicamente relevante en una diferencia de medias en el FEV1 mayor que &#43;100<span class="elsevierStyleHsp" style=""></span>mL&#46; Sig&#46;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>estad&#237;sticamente significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Santib&#225;&#241;ez, Juan Luis Garc&#237;a-Rivero, Esther Barreiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Santib&#225;&#241;ez"
            ]
            1 => array:2 [
              "nombre" => "Juan Luis"
              "apellidos" => "Garc&#237;a-Rivero"
            ]
            2 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Barreiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212920302068"
        "doi" => "10.1016/j.arbr.2019.11.017"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212920302068?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305733?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305733/v2_202010270642/es/main.assets"
  ]
  "es" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Duraci&#243;n de la anticoagulaci&#243;n tras una tromboembolia de pulm&#243;n&#58; una decisi&#243;n no siempre sencilla"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "617"
        "paginaFinal" => "618"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Andr&#233;s Quezada, David Jim&#233;nez"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "Quezada"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "David"
            "apellidos" => "Jim&#233;nez"
            "email" => array:1 [
              0 => "djimenez.hrc@gmail.com"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Ram&#243;n y Cajal &#40;IRYCIS&#41;&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Departamento de Medicina&#44; Universidad de Alcal&#225; &#40;IRYCIS&#41;&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Duration of Anticoagulant Therapy After Pulmonary Embolism Can Be a Tough Decision"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Despu&#233;s de un episodio de tromboembolia de pulm&#243;n &#40;TEP&#41; aguda sintom&#225;tica&#44; los pacientes necesitan un m&#237;nimo de 3 a 6 meses de tratamiento anticoagulante&#44; siempre que no haya contraindicaci&#243;n absoluta para su uso<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Es en ese momento cuando los cl&#237;nicos debemos tomar una de las decisiones m&#225;s importantes en el manejo de los pacientes con enfermedad tromboemb&#243;lica venosa &#40;ETEV&#41;&#44; que es la duraci&#243;n del tratamiento anticoagulante&#46; Aunque la anticoagulaci&#243;n indefinida con antagonistas de la vitamina K reduce el riesgo de recurrencias un 90&#37; aproximadamente&#44; su uso multiplica por 2-6 el riesgo de sangrados mayores<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a>&#46; Adicionalmente&#44; los anticoagulantes &#171;protegen&#187; a los pacientes &#250;nicamente mientras los usan<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">3</span></a>&#44; por lo que la decisi&#243;n no consiste en establecer un per&#237;odo definido de tratamiento &#40;e&#46;g&#46;&#44; 9 meses&#44; 12 meses&#44; 24 meses&#41;&#44; sino en suspender la anticoagulaci&#243;n o indicarla de manera indefinida &#40;i&#46;e&#46;&#44; sin un momento definido para su suspensi&#243;n&#41;&#46; Esta decisi&#243;n debe combinar el riesgo de recurrencia &#40;al suspender la anticoagulaci&#243;n&#41;&#44; el riesgo de sangrado &#40;al mantenerla&#41; y las preferencias del propio paciente<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">El balance riesgo&#47;beneficio es claro en algunos subgrupos de pacientes&#46; Los pacientes diagnosticados de una TEP secundaria a un factor de riesgo mayor&#44; transitorio y resuelto&#44; tienen un riesgo de recurrencia muy bajo al suspender la anticoagulaci&#243;n &#40;aproximadamente un 1&#37; en el primer a&#241;o y un 3&#37; en los 5 a&#241;os siguientes&#41;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">4</span></a>&#44; y las gu&#237;as de pr&#225;ctica cl&#237;nica recomiendan suspenderla despu&#233;s de 3 meses de tratamiento&#46; En el otro extremo del espectro se encuentran los pacientes con una factor de riesgo mayor persistente &#40;e&#46;g&#46;&#44; c&#225;ncer activo&#44; s&#237;ndrome antifosfolip&#237;dico&#44; historia de 2 o m&#225;s episodios tromb&#243;ticos idiop&#225;ticos&#41;&#46; Estos pacientes tienen un riesgo muy alto de recurrencia al suspender la anticoagulaci&#243;n y deber&#237;an recibirla de forma indefinida&#44; o hasta que el factor de riesgo haya desaparecido &#40;e&#46;g&#46;&#44; curaci&#243;n del c&#225;ncer&#41;&#44; siempre que el riesgo de sangrado no sea alto&#46; Los pacientes con TEP idiop&#225;tica tienen un riesgo de recurrencia de un 10&#37; en el primer a&#241;o&#44; y de un 30&#37; en los 5 a&#241;os siguientes a suspender la anticoagulaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">5</span></a>&#44; y las gu&#237;as de pr&#225;ctica cl&#237;nica recomiendan tratamiento anticoagulante indefinido&#46; Nosotros recomendamos anticoagulaci&#243;n indefinida a todos los hombres con TEP idiop&#225;tica &#40;sin un riesgo alto de sangrado&#41;&#44; ya que tienen un riesgo 2&#44;2 veces mayor de recurrencia que las mujeres<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">6</span></a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Algunos subgrupos de pacientes se podr&#237;an beneficiar de informaci&#243;n adicional para evaluar mejor el riesgo de recurrencia al suspender la anticoagulaci&#243;n&#44; bien de forma aislada &#40;caracter&#237;sticas cl&#237;nicas&#44; d&#237;mero D&#44; estudios de trombofilia&#41;&#44; o bien combinada en forma de escalas predictoras &#40;modelo de Viena<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">7</span></a>&#44; DASH<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&#44; HERDOO2<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#58;<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1&#46;</span><p id="par0020" class="elsevierStylePara elsevierViewall">Las mujeres con antecedentes de TEP idiop&#225;tica&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2&#46;</span><p id="par0025" class="elsevierStylePara elsevierViewall">Los pacientes con antecedentes de TEP secundaria a un factor de riesgo menor&#44; transitorio y resuelto &#40;e&#46;g&#46;&#44; uso de estr&#243;genos&#44; viajes prolongados&#44; inmovilizaci&#243;n&#44; cirug&#237;a menor&#41; &#40;riesgo de recurrencia del 5&#37; en el primer a&#241;o y del 15&#37; en los primeros 5 a&#241;os despu&#233;s de suspender la anticoagulaci&#243;n&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3&#46;</span><p id="par0030" class="elsevierStylePara elsevierViewall">Los pacientes que desean suspender la anticoagulaci&#243;n &#40;con independencia de su riesgo de recurrencia&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4&#46;</span><p id="par0035" class="elsevierStylePara elsevierViewall">Aquellos pacientes en los que percibimos una relaci&#243;n riesgo&#47;beneficio estrecha para el uso de tratamiento anticoagulante indefinido &#40;e&#46;g&#46;&#44; pacientes con riesgo moderado de sangrado&#41;&#46;</p></li></ul></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">En estos grupos&#44; la acumulaci&#243;n de factores de riesgo de recurrencia hace que nos inclinemos por el tratamiento indefinido&#44; mientras que la ausencia de estos factores hace que nos inclinemos por suspender la anticoagulaci&#243;n&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">En cualquier caso&#44; ninguna de las recomendaciones ni de los predictores de recurrencia antes mencionados deber&#237;an ser usados de forma dogm&#225;tica y siempre se deber&#237;an aplicar en funci&#243;n de la experiencia cl&#237;nica para tomar la mejor decisi&#243;n sobre la duraci&#243;n de la anticoagulaci&#243;n&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ETEV&#58; enfermedad tromboemb&#243;lica venosa&#59; TEP&#58; tromboembolia pulmonar&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Factor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Comentarios&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">D&#237;mero D elevado<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">10</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Un d&#237;mero D elevado al mes de suspender la anticoagulaci&#243;n favorece el tratamiento indefinido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TEP de riesgo alto o de riesgo intermedio-alto&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aunque no hay datos concluyentes&#44; la gravedad de la presentaci&#243;n favorece el tratamiento indefinido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hipertensi&#243;n pulmonar persistente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Su forma m&#225;s grave&#44; la hipertensi&#243;n pulmonar tromboemb&#243;lica cr&#243;nica&#44; obliga al tratamiento anticoagulante de por vida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Trombosis residual&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La obstrucci&#243;n vascular residual est&#225; siendo estudiada como factor de riesgo de recurrencia al suspender la anticoagulaci&#243;n &#40;PROSPERO CRD42017081080&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Modelo de Viena<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">7</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">En pacientes con ETEV idiop&#225;tica&#44; estima el riesgo de recurrencia al suspender la anticoagulaci&#243;n seg&#250;n el sexo&#44; la localizaci&#243;n de la ETEV y los niveles de d&#237;mero D&#46; No ha sido adecuadamente validado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Escala DASH<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Un d&#237;mero D elevado&#44; edad &#60;<span class="elsevierStyleHsp" style=""></span>50 a&#241;os&#44; sexo var&#243;n y ETEV no asociada al uso de estr&#243;genos se asocian a un riesgo aumentado de recurrencia al suspender la anticoagulaci&#243;n en pacientes con ETEV idiop&#225;tica&#46; No ha sido adecuadamente validada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Escala HERDOO2<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hiperpigmentaci&#243;n&#44; edema y&#47;o enrojecimiento de la pierna &#40;1 punto por la presencia de &#8805;<span class="elsevierStyleHsp" style=""></span>1 de ellas&#41;&#44; d&#237;mero D<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>250<span class="elsevierStyleHsp" style=""></span>ng&#47;mL mientras la paciente recibe anticoagulaci&#243;n &#40;1 punto&#41;&#44; obesidad &#40;&#237;ndice masa corporal<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>kg&#47;m<span class="elsevierStyleSup">2</span>&#41; &#40;1 punto&#41; y edad<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>65 a&#241;os &#40;1 punto&#41;&#46; Habitualmente recomendamos suspender la anticoagulaci&#243;n a las mujeres con TEP idiop&#225;tica y una puntuaci&#243;n &#60;<span class="elsevierStyleHsp" style=""></span>2&#44; y mantenerla de forma indefinida a aquellas con &#8805;<span class="elsevierStyleHsp" style=""></span>2 puntos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Trombofilia hereditaria<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">11</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">De forma aislada es poco &#250;til para tomar decisiones sobre la duraci&#243;n del tratamiento y no recomendamos su determinaci&#243;n rutinaria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2408953.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">En los siguientes subgrupos de pacientes&#58; mujeres con TEP idiop&#225;tica&#44; los pacientes con antecedentes de TEP secundaria a un factor de riesgo menor&#44; transitorio y resuelto&#44; los pacientes que desean suspender la anticoagulaci&#243;n o los pacientes con una relaci&#243;n riesgo&#47;beneficio estrecha para el uso de tratamiento anticoagulante indefinido&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Factores que orientan al uso de anticoagulaci&#243;n indefinida<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:11 [
            0 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antithrombotic therapy for VTE disease&#58; Chest guideline and expert panel report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                            2 => "J&#46; Ornelas"
                            3 => "A&#46; Blaivas"
                            4 => "D&#46; Jimenez"
                            5 => "H&#46; Bounameaux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Chest&#46;"
                        "fecha" => "2016"
                        "volumen" => "149"
                        "paginaInicial" => "315"
                        "paginaFinal" => "352"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-12-512681"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood&#46;"
                        "fecha" => "2014"
                        "volumen" => "123"
                        "paginaInicial" => "1794"
                        "paginaFinal" => "1801"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24497538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society &#40;ERS&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "ESC Scientific Document Group"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;V&#46; Konstantinides"
                            1 => "G&#46; Meyer"
                            2 => "C&#46; Becattini"
                            3 => "H&#46; Bueno"
                            4 => "G&#46;J&#46; Geersing"
                            5 => "V&#46;P&#46; Harjola"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehz405"
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Heart J&#46;"
                        "fecha" => "2019"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27141094"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Six months vs extended oral anticoagulation after a first episode of pulmonary embolism&#58; The PADIS-PE randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PADIS-PE Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Couturaud"
                            1 => "O&#46; Sanchez"
                            2 => "G&#46; Pernod"
                            3 => "P&#46; Mismetti"
                            4 => "P&#46; Jego"
                            5 => "E&#46; Duhamel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.7046"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "31"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26151264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism&#46; A prospective cohort study in 1&#44;626 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "F&#46; Noventa"
                            2 => "A&#46; Ghirarduzzi"
                            3 => "V&#46; Pengo"
                            4 => "E&#46; Bernardi"
                            5 => "R&#46; Pesavento"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3324/haematol.10516"
                      "Revista" => array:6 [
                        "tituloSerie" => "Haematologica&#46;"
                        "fecha" => "2007"
                        "volumen" => "92"
                        "paginaInicial" => "199"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17296569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of recurrence after venous thromboembolism in men and women&#58; patient level meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Douketis"
                            1 => "A&#46; Tosetto"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "B&#46; Cosmi"
                            5 => "M&#46; Cushman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2011"
                        "volumen" => "342"
                        "paginaInicial" => "d813"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism&#58; the Vienna prediction model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46; Eichinger"
                            1 => "G&#46; Heinze"
                            2 => "L&#46;M&#46; Jandeck"
                            3 => "P&#46;A&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.109.925214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation&#46;"
                        "fecha" => "2013"
                        "volumen" => "121"
                        "paginaInicial" => "1630"
                        "paginaFinal" => "1636"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20351233"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism&#58; a proposed prediction score &#40;DASH&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Tosetto"
                            1 => "A&#46; Iorio"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "M&#46; Cushman"
                            5 => "S&#46; Eichinger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1538-7836.2012.04735.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Thromb Haemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "10"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1025"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22489957"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis&#58; multinational prospective cohort management study"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "REVERSE II Study Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;A&#46; Rodger"
                            1 => "G&#46; Le Gal"
                            2 => "D&#46;R&#46; Anderson"
                            3 => "J&#46; Schmidt"
                            4 => "G&#46; Pernod"
                            5 => "S&#46;R&#46; Kahn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.j1065"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2017"
                        "volumen" => "356"
                        "paginaInicial" => "j1065"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28314711"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "D-dimer testing to determine the duration of anticoagulation therapy"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PROLONG Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Palareti"
                            1 => "B&#46; Cosmi"
                            2 => "C&#46; Legnani"
                            3 => "A&#46; Tosetto"
                            4 => "C&#46; Brusi"
                            5 => "A&#46; Iorio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa054444"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2006"
                        "volumen" => "355"
                        "paginaInicial" => "1780"
                        "paginaFinal" => "1789"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17065639"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Thrombophilia&#44; clinical factors&#44; and recurrent venous thrombotic events"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;C&#46; Christiansen"
                            1 => "S&#46;C&#46; Cannegieter"
                            2 => "T&#46; Koster"
                            3 => "J&#46;P&#46; Vandenbroucke"
                            4 => "F&#46;R&#46; Rosendaal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.293.19.2352"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2005"
                        "volumen" => "293"
                        "paginaInicial" => "2352"
                        "paginaFinal" => "2361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15900005"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305745/v2_202010270642/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "14517"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorials / Editoriales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005600000010/v2_202010270642/S0300289619305745/v2_202010270642/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305745?idApp=UINPBA00003Z"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Duración de la anticoagulación tras una tromboembolia de pulmón: una decisión no siempre sencilla
Duration of Anticoagulant Therapy After Pulmonary Embolism Can Be a Tough Decision
Andrés Quezadaa, David Jiméneza,b,
Corresponding author
djimenez.hrc@gmail.com

Autor para correspondencia.
a Servicio de Neumología, Hospital Ramón y Cajal (IRYCIS), Madrid, España
b Departamento de Medicina, Universidad de Alcalá (IRYCIS), Madrid, España
Read
3730
Times
was read the article
936
Total PDF
2794
Total HTML
Share statistics
 array:24 [
  "pii" => "S0300289619305745"
  "issn" => "03002896"
  "doi" => "10.1016/j.arbres.2019.11.007"
  "estado" => "S300"
  "fechaPublicacion" => "2020-10-01"
  "aid" => "2324"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "edi"
  "cita" => "Arch Bronconeumol. 2020;56:617-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 60
    "formatos" => array:2 [
      "HTML" => 31
      "PDF" => 29
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S157921292030207X"
      "issn" => "15792129"
      "doi" => "10.1016/j.arbr.2019.11.018"
      "estado" => "S300"
      "fechaPublicacion" => "2020-10-01"
      "aid" => "2324"
      "copyright" => "SEPAR"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "edi"
      "cita" => "Arch Bronconeumol. 2020;56:617-8"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Duration of anticoagulant therapy after pulmonary embolism can be a tough decision"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "617"
            "paginaFinal" => "618"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Duraci&#243;n de la anticoagulaci&#243;n tras una tromboembolia de pulm&#243;n&#58; una decisi&#243;n no siempre sencilla"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Andr&#233;s Quezada, David Jim&#233;nez"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Andr&#233;s"
                "apellidos" => "Quezada"
              ]
              1 => array:2 [
                "nombre" => "David"
                "apellidos" => "Jim&#233;nez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0300289619305745"
          "doi" => "10.1016/j.arbres.2019.11.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305745?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921292030207X?idApp=UINPBA00003Z"
      "url" => "/15792129/0000005600000010/v1_202010020808/S157921292030207X/v1_202010020808/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0300289619305836"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2019.11.013"
    "estado" => "S300"
    "fechaPublicacion" => "2020-10-01"
    "aid" => "2333"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "edi"
    "cita" => "Arch Bronconeumol. 2020;56:619-20"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14
      "formatos" => array:2 [
        "HTML" => 8
        "PDF" => 6
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "La fisioterapia respiratoria en el s&#237;ndrome de <span class="elsevierStyleItalic">Lady Windermere</span>&#58; &#191;el eslab&#243;n perdido&#63;"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "619"
          "paginaFinal" => "620"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Respiratory Physiotherapy in Lady Windermere Syndrome&#58; The Missing Link&#63;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Bala&#241;&#225; Corber&#243;, Marisol Dom&#237;nguez-&#193;lvarez, Esther Barreiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Bala&#241;&#225; Corber&#243;"
            ]
            1 => array:2 [
              "nombre" => "Marisol"
              "apellidos" => "Dom&#237;nguez-&#193;lvarez"
            ]
            2 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Barreiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212920302081"
        "doi" => "10.1016/j.arbr.2019.11.019"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212920302081?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305836?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305836/v2_202010270642/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0300289619305733"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2019.11.006"
    "estado" => "S300"
    "fechaPublicacion" => "2020-10-01"
    "aid" => "2323"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "edi"
    "cita" => "Arch Bronconeumol. 2020;56:615-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 38
      "formatos" => array:2 [
        "HTML" => 23
        "PDF" => 15
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "&#191;Estad&#237;sticamente significativo o cl&#237;nicamente Important&#63;"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "615"
          "paginaFinal" => "616"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Statistically Significant or Clinically Relevant&#63;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 903
              "Ancho" => 2085
              "Tamanyo" => 116441
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Interpretaci&#243;n de la relevancia cl&#237;nica de ejemplos de intervalos de confianza al 95&#37;&#44; en el que se ha establecido el umbral para la diferencia m&#237;nima cl&#237;nicamente relevante en una diferencia de medias en el FEV1 mayor que &#43;100<span class="elsevierStyleHsp" style=""></span>mL&#46; Sig&#46;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>estad&#237;sticamente significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Santib&#225;&#241;ez, Juan Luis Garc&#237;a-Rivero, Esther Barreiro"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Santib&#225;&#241;ez"
            ]
            1 => array:2 [
              "nombre" => "Juan Luis"
              "apellidos" => "Garc&#237;a-Rivero"
            ]
            2 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Barreiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212920302068"
        "doi" => "10.1016/j.arbr.2019.11.017"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212920302068?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305733?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305733/v2_202010270642/es/main.assets"
  ]
  "es" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Duraci&#243;n de la anticoagulaci&#243;n tras una tromboembolia de pulm&#243;n&#58; una decisi&#243;n no siempre sencilla"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "617"
        "paginaFinal" => "618"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Andr&#233;s Quezada, David Jim&#233;nez"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "Quezada"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "David"
            "apellidos" => "Jim&#233;nez"
            "email" => array:1 [
              0 => "djimenez.hrc@gmail.com"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Ram&#243;n y Cajal &#40;IRYCIS&#41;&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Departamento de Medicina&#44; Universidad de Alcal&#225; &#40;IRYCIS&#41;&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Duration of Anticoagulant Therapy After Pulmonary Embolism Can Be a Tough Decision"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Despu&#233;s de un episodio de tromboembolia de pulm&#243;n &#40;TEP&#41; aguda sintom&#225;tica&#44; los pacientes necesitan un m&#237;nimo de 3 a 6 meses de tratamiento anticoagulante&#44; siempre que no haya contraindicaci&#243;n absoluta para su uso<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Es en ese momento cuando los cl&#237;nicos debemos tomar una de las decisiones m&#225;s importantes en el manejo de los pacientes con enfermedad tromboemb&#243;lica venosa &#40;ETEV&#41;&#44; que es la duraci&#243;n del tratamiento anticoagulante&#46; Aunque la anticoagulaci&#243;n indefinida con antagonistas de la vitamina K reduce el riesgo de recurrencias un 90&#37; aproximadamente&#44; su uso multiplica por 2-6 el riesgo de sangrados mayores<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a>&#46; Adicionalmente&#44; los anticoagulantes &#171;protegen&#187; a los pacientes &#250;nicamente mientras los usan<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">3</span></a>&#44; por lo que la decisi&#243;n no consiste en establecer un per&#237;odo definido de tratamiento &#40;e&#46;g&#46;&#44; 9 meses&#44; 12 meses&#44; 24 meses&#41;&#44; sino en suspender la anticoagulaci&#243;n o indicarla de manera indefinida &#40;i&#46;e&#46;&#44; sin un momento definido para su suspensi&#243;n&#41;&#46; Esta decisi&#243;n debe combinar el riesgo de recurrencia &#40;al suspender la anticoagulaci&#243;n&#41;&#44; el riesgo de sangrado &#40;al mantenerla&#41; y las preferencias del propio paciente<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">El balance riesgo&#47;beneficio es claro en algunos subgrupos de pacientes&#46; Los pacientes diagnosticados de una TEP secundaria a un factor de riesgo mayor&#44; transitorio y resuelto&#44; tienen un riesgo de recurrencia muy bajo al suspender la anticoagulaci&#243;n &#40;aproximadamente un 1&#37; en el primer a&#241;o y un 3&#37; en los 5 a&#241;os siguientes&#41;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">4</span></a>&#44; y las gu&#237;as de pr&#225;ctica cl&#237;nica recomiendan suspenderla despu&#233;s de 3 meses de tratamiento&#46; En el otro extremo del espectro se encuentran los pacientes con una factor de riesgo mayor persistente &#40;e&#46;g&#46;&#44; c&#225;ncer activo&#44; s&#237;ndrome antifosfolip&#237;dico&#44; historia de 2 o m&#225;s episodios tromb&#243;ticos idiop&#225;ticos&#41;&#46; Estos pacientes tienen un riesgo muy alto de recurrencia al suspender la anticoagulaci&#243;n y deber&#237;an recibirla de forma indefinida&#44; o hasta que el factor de riesgo haya desaparecido &#40;e&#46;g&#46;&#44; curaci&#243;n del c&#225;ncer&#41;&#44; siempre que el riesgo de sangrado no sea alto&#46; Los pacientes con TEP idiop&#225;tica tienen un riesgo de recurrencia de un 10&#37; en el primer a&#241;o&#44; y de un 30&#37; en los 5 a&#241;os siguientes a suspender la anticoagulaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">5</span></a>&#44; y las gu&#237;as de pr&#225;ctica cl&#237;nica recomiendan tratamiento anticoagulante indefinido&#46; Nosotros recomendamos anticoagulaci&#243;n indefinida a todos los hombres con TEP idiop&#225;tica &#40;sin un riesgo alto de sangrado&#41;&#44; ya que tienen un riesgo 2&#44;2 veces mayor de recurrencia que las mujeres<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">6</span></a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Algunos subgrupos de pacientes se podr&#237;an beneficiar de informaci&#243;n adicional para evaluar mejor el riesgo de recurrencia al suspender la anticoagulaci&#243;n&#44; bien de forma aislada &#40;caracter&#237;sticas cl&#237;nicas&#44; d&#237;mero D&#44; estudios de trombofilia&#41;&#44; o bien combinada en forma de escalas predictoras &#40;modelo de Viena<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">7</span></a>&#44; DASH<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&#44; HERDOO2<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#58;<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1&#46;</span><p id="par0020" class="elsevierStylePara elsevierViewall">Las mujeres con antecedentes de TEP idiop&#225;tica&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2&#46;</span><p id="par0025" class="elsevierStylePara elsevierViewall">Los pacientes con antecedentes de TEP secundaria a un factor de riesgo menor&#44; transitorio y resuelto &#40;e&#46;g&#46;&#44; uso de estr&#243;genos&#44; viajes prolongados&#44; inmovilizaci&#243;n&#44; cirug&#237;a menor&#41; &#40;riesgo de recurrencia del 5&#37; en el primer a&#241;o y del 15&#37; en los primeros 5 a&#241;os despu&#233;s de suspender la anticoagulaci&#243;n&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3&#46;</span><p id="par0030" class="elsevierStylePara elsevierViewall">Los pacientes que desean suspender la anticoagulaci&#243;n &#40;con independencia de su riesgo de recurrencia&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4&#46;</span><p id="par0035" class="elsevierStylePara elsevierViewall">Aquellos pacientes en los que percibimos una relaci&#243;n riesgo&#47;beneficio estrecha para el uso de tratamiento anticoagulante indefinido &#40;e&#46;g&#46;&#44; pacientes con riesgo moderado de sangrado&#41;&#46;</p></li></ul></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">En estos grupos&#44; la acumulaci&#243;n de factores de riesgo de recurrencia hace que nos inclinemos por el tratamiento indefinido&#44; mientras que la ausencia de estos factores hace que nos inclinemos por suspender la anticoagulaci&#243;n&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">En cualquier caso&#44; ninguna de las recomendaciones ni de los predictores de recurrencia antes mencionados deber&#237;an ser usados de forma dogm&#225;tica y siempre se deber&#237;an aplicar en funci&#243;n de la experiencia cl&#237;nica para tomar la mejor decisi&#243;n sobre la duraci&#243;n de la anticoagulaci&#243;n&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ETEV&#58; enfermedad tromboemb&#243;lica venosa&#59; TEP&#58; tromboembolia pulmonar&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Factor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Comentarios&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">D&#237;mero D elevado<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">10</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Un d&#237;mero D elevado al mes de suspender la anticoagulaci&#243;n favorece el tratamiento indefinido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TEP de riesgo alto o de riesgo intermedio-alto&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aunque no hay datos concluyentes&#44; la gravedad de la presentaci&#243;n favorece el tratamiento indefinido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hipertensi&#243;n pulmonar persistente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Su forma m&#225;s grave&#44; la hipertensi&#243;n pulmonar tromboemb&#243;lica cr&#243;nica&#44; obliga al tratamiento anticoagulante de por vida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Trombosis residual&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La obstrucci&#243;n vascular residual est&#225; siendo estudiada como factor de riesgo de recurrencia al suspender la anticoagulaci&#243;n &#40;PROSPERO CRD42017081080&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Modelo de Viena<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">7</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">En pacientes con ETEV idiop&#225;tica&#44; estima el riesgo de recurrencia al suspender la anticoagulaci&#243;n seg&#250;n el sexo&#44; la localizaci&#243;n de la ETEV y los niveles de d&#237;mero D&#46; No ha sido adecuadamente validado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Escala DASH<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Un d&#237;mero D elevado&#44; edad &#60;<span class="elsevierStyleHsp" style=""></span>50 a&#241;os&#44; sexo var&#243;n y ETEV no asociada al uso de estr&#243;genos se asocian a un riesgo aumentado de recurrencia al suspender la anticoagulaci&#243;n en pacientes con ETEV idiop&#225;tica&#46; No ha sido adecuadamente validada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Escala HERDOO2<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hiperpigmentaci&#243;n&#44; edema y&#47;o enrojecimiento de la pierna &#40;1 punto por la presencia de &#8805;<span class="elsevierStyleHsp" style=""></span>1 de ellas&#41;&#44; d&#237;mero D<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>250<span class="elsevierStyleHsp" style=""></span>ng&#47;mL mientras la paciente recibe anticoagulaci&#243;n &#40;1 punto&#41;&#44; obesidad &#40;&#237;ndice masa corporal<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>kg&#47;m<span class="elsevierStyleSup">2</span>&#41; &#40;1 punto&#41; y edad<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>65 a&#241;os &#40;1 punto&#41;&#46; Habitualmente recomendamos suspender la anticoagulaci&#243;n a las mujeres con TEP idiop&#225;tica y una puntuaci&#243;n &#60;<span class="elsevierStyleHsp" style=""></span>2&#44; y mantenerla de forma indefinida a aquellas con &#8805;<span class="elsevierStyleHsp" style=""></span>2 puntos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Trombofilia hereditaria<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">11</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">De forma aislada es poco &#250;til para tomar decisiones sobre la duraci&#243;n del tratamiento y no recomendamos su determinaci&#243;n rutinaria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2408953.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">En los siguientes subgrupos de pacientes&#58; mujeres con TEP idiop&#225;tica&#44; los pacientes con antecedentes de TEP secundaria a un factor de riesgo menor&#44; transitorio y resuelto&#44; los pacientes que desean suspender la anticoagulaci&#243;n o los pacientes con una relaci&#243;n riesgo&#47;beneficio estrecha para el uso de tratamiento anticoagulante indefinido&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Factores que orientan al uso de anticoagulaci&#243;n indefinida<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:11 [
            0 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antithrombotic therapy for VTE disease&#58; Chest guideline and expert panel report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                            2 => "J&#46; Ornelas"
                            3 => "A&#46; Blaivas"
                            4 => "D&#46; Jimenez"
                            5 => "H&#46; Bounameaux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Chest&#46;"
                        "fecha" => "2016"
                        "volumen" => "149"
                        "paginaInicial" => "315"
                        "paginaFinal" => "352"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-12-512681"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood&#46;"
                        "fecha" => "2014"
                        "volumen" => "123"
                        "paginaInicial" => "1794"
                        "paginaFinal" => "1801"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24497538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society &#40;ERS&#41;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "ESC Scientific Document Group"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;V&#46; Konstantinides"
                            1 => "G&#46; Meyer"
                            2 => "C&#46; Becattini"
                            3 => "H&#46; Bueno"
                            4 => "G&#46;J&#46; Geersing"
                            5 => "V&#46;P&#46; Harjola"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehz405"
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Heart J&#46;"
                        "fecha" => "2019"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27141094"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Six months vs extended oral anticoagulation after a first episode of pulmonary embolism&#58; The PADIS-PE randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PADIS-PE Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Couturaud"
                            1 => "O&#46; Sanchez"
                            2 => "G&#46; Pernod"
                            3 => "P&#46; Mismetti"
                            4 => "P&#46; Jego"
                            5 => "E&#46; Duhamel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.7046"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "31"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26151264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism&#46; A prospective cohort study in 1&#44;626 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "F&#46; Noventa"
                            2 => "A&#46; Ghirarduzzi"
                            3 => "V&#46; Pengo"
                            4 => "E&#46; Bernardi"
                            5 => "R&#46; Pesavento"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3324/haematol.10516"
                      "Revista" => array:6 [
                        "tituloSerie" => "Haematologica&#46;"
                        "fecha" => "2007"
                        "volumen" => "92"
                        "paginaInicial" => "199"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17296569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of recurrence after venous thromboembolism in men and women&#58; patient level meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Douketis"
                            1 => "A&#46; Tosetto"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "B&#46; Cosmi"
                            5 => "M&#46; Cushman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2011"
                        "volumen" => "342"
                        "paginaInicial" => "d813"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism&#58; the Vienna prediction model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46; Eichinger"
                            1 => "G&#46; Heinze"
                            2 => "L&#46;M&#46; Jandeck"
                            3 => "P&#46;A&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.109.925214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation&#46;"
                        "fecha" => "2013"
                        "volumen" => "121"
                        "paginaInicial" => "1630"
                        "paginaFinal" => "1636"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20351233"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism&#58; a proposed prediction score &#40;DASH&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Tosetto"
                            1 => "A&#46; Iorio"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "M&#46; Cushman"
                            5 => "S&#46; Eichinger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1538-7836.2012.04735.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Thromb Haemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "10"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1025"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22489957"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis&#58; multinational prospective cohort management study"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "REVERSE II Study Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;A&#46; Rodger"
                            1 => "G&#46; Le Gal"
                            2 => "D&#46;R&#46; Anderson"
                            3 => "J&#46; Schmidt"
                            4 => "G&#46; Pernod"
                            5 => "S&#46;R&#46; Kahn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.j1065"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2017"
                        "volumen" => "356"
                        "paginaInicial" => "j1065"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28314711"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "D-dimer testing to determine the duration of anticoagulation therapy"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PROLONG Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Palareti"
                            1 => "B&#46; Cosmi"
                            2 => "C&#46; Legnani"
                            3 => "A&#46; Tosetto"
                            4 => "C&#46; Brusi"
                            5 => "A&#46; Iorio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa054444"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2006"
                        "volumen" => "355"
                        "paginaInicial" => "1780"
                        "paginaFinal" => "1789"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17065639"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Thrombophilia&#44; clinical factors&#44; and recurrent venous thrombotic events"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;C&#46; Christiansen"
                            1 => "S&#46;C&#46; Cannegieter"
                            2 => "T&#46; Koster"
                            3 => "J&#46;P&#46; Vandenbroucke"
                            4 => "F&#46;R&#46; Rosendaal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.293.19.2352"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2005"
                        "volumen" => "293"
                        "paginaInicial" => "2352"
                        "paginaFinal" => "2361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15900005"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/03002896/0000005600000010/v2_202010270642/S0300289619305745/v2_202010270642/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "14517"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorials / Editoriales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005600000010/v2_202010270642/S0300289619305745/v2_202010270642/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289619305745?idApp=UINPBA00003Z"
]
Article information
ISSN: 03002896
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 32 2 34
2024 October 317 26 343
2024 September 225 24 249
2024 August 182 41 223
2024 July 133 19 152
2024 June 124 28 152
2024 May 129 26 155
2024 April 74 25 99
2024 March 78 23 101
2024 February 52 22 74
2024 January 1 2 3
2023 December 3 0 3
2023 November 3 4 7
2023 August 2 4 6
2023 July 7 0 7
2023 May 2 0 2
2023 April 2 0 2
2023 March 23 4 27
2023 February 68 13 81
2023 January 65 36 101
2022 December 92 32 124
2022 November 105 30 135
2022 October 100 30 130
2022 September 60 28 88
2022 August 68 41 109
2022 July 60 36 96
2022 June 59 26 85
2022 May 55 42 97
2022 April 64 36 100
2022 March 62 36 98
2022 February 36 16 52
2022 January 2 0 2
2021 December 2 2 4
2021 November 2 2 4
2021 October 27 0 27
2021 September 1 4 5
2021 August 4 0 4
2021 July 17 5 22
2021 June 8 7 15
2021 May 7 6 13
2021 April 11 16 27
2021 March 3 4 7
2021 February 8 6 14
2021 January 11 10 21
2020 December 38 20 58
2020 November 62 18 80
2020 October 248 139 387
2020 July 1 2 3
2020 June 2 4 6
2020 May 6 2 8
2020 April 13 4 17
2020 March 5 4 9
2020 February 8 2 10
2020 January 25 27 52
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?